Catherine Wolfel

Mainz, RP 55101, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Journal: Blood

Published: October 03, 2025

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Journal: Blood

Published: October 03, 2025

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma.

Journal: International journal of molecular sciences

Published: June 10, 2025

Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engager.

Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engager.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: February 26, 2025

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H.

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H.

Journal: Frontiers in immunology

Published: October 11, 2024

Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires.

Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires.

Journal: Frontiers in immunology

Published: August 31, 2023

Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors.

Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors.

Journal: Frontiers in immunology

Published: June 23, 2023

Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy.

Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy.

Journal: Cell reports. Medicine

Published: August 31, 2022

A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequences.

A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequences.

Journal: PloS one

Published: March 19, 2020

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.

Journal: Oncotarget

Published: July 05, 2016

Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells.

Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells.

Journal: Journal of innate immunity

Published: February 12, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026